Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02190968 · ClinicalTrials.gov registry record · NA
Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance
A NA study, sponsored by University of Toronto.
- Completed
- Registry status
- NA
- Development phase
- 460
- Enrollment target
NCT02190968: Completed NA study, sponsored by University of Toronto.
NCT02190968 is a NA study that has completed, run by University of Toronto. The registered enrollment target is 460 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02190968, a NA study, has completed, sponsored by University of Toronto.
- COMPLETED
- Registry status
- NA
- Development phase
- 460 participants
- Enrollment target
Study Summary
Many patients report residual depressive symptoms despite seemingly successful treatment. With the investigators' previous funding, we developed - Mindful Mood Balance - an online treatment that targets RDS by teaching specific emotion regulation and depression self-management skills that are entirely compatible with antidepressant treatment. The investigators now propose a controlled study to determine whether MMB is more effective than usual care at reducing RDS and other key outcomes. If successful, MMB's online delivery format would provide high fidelity and low-cost empirically supported management of residual symptoms, leading to more robust remission, improved functioning and sustained recovery from MDD over time.
Primary Outcome
Changes in self reported depressive symptom severity
Interventions
- BEHAVIORAL Usual Depression Care
- BEHAVIORAL Mindful Mood Balance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-11 |
| Phase | NA |
What the finished NCT02190968 record still lists
NCT02190968 is an interventional study that assigns participants to a tested intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Depression Care is the first listed.
NCT02190968 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02190968 about?
NCT02190968 is a clinical study titled "Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance". Many patients report residual depressive symptoms despite seemingly successful treatment. With the investigators' previous funding, we developed - Mindful Mood Balance - an online treatment that targets RDS by teaching specific emotion regulation and depression self-management skills that are entire...
What is the current status of trial NCT02190968?
This trial is currently completed. It is a NA study. The enrollment target is 460 participants. The study started on 2015-03. Estimated completion is 2018-11.
What interventions are being tested in trial NCT02190968?
The interventions under investigation include: Usual Depression Care (BEHAVIORAL), Mindful Mood Balance (BEHAVIORAL).
Who is sponsoring clinical trial NCT02190968?
This trial is sponsored by University of Toronto, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02190968's enrollment target sits among peer trials
460 222nd of 2000 higher than 1,777 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
- NCT04621279 · 460 participants
Cool Prime Comparative Effectiveness Study for Mild HIE
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia